Abstract:Nuclear factor (NF)-kappaB transcription factors are involved in the control of a large number of normal cellular and organismal processes, such as immune and inflammatory responses, developmental processes, cellular growth, and apoptosis. Transcription of the human immunodeficiency virus type 1 (HIV-1) genome depends on the intracellular environment where the integrate viral DNA is regulated by a complex interplay among viral regulatory proteins, such as Tat, and host cellular transcription factors, such as NF-kappaB, interacting with the viral long terminal repeat region. CBP (CREB-binding protein) and p300, containing an intrinsic histone acetyltransferase (HAT) activity, have emerged as coactivators for various DNA-binding transcription factors. Here, we show that the p50 subunit as well as the p50/p65 of NF-kappaB, and not other factors such as SP1, TFIIB, polymerase II, TFIIA, or p65, can be acetylated by CBP/p300 HAT domain. Acetylation of p50 was completely dependent on the presence of both HAT domain and Tat proteins, implying that Tat influences the transcription machinery by aiding CBP/p300 to acquire new partners and increase its functional repertoire. Three lysines, Lys-431, Lys-440, and Lys-441 in p50 were all acetylated an vitro, and a sequence similarity among p50, p53, Tat, and activin receptor type I on these particular lysines was observed. All proteins have been shown to be acetylated by the CBP/p300 HAT domain. Acetylated p50 increases its DNA binding properties, as evident by streptavidin/biotin pull-down assays when using labeled NF-kappaB oligonucleotides. Increased DNA binding on HIV-1 long terminal repeat coincided with increases in the rate of transcription. Therefore, we propose that acetylation of the DNA binding domain of NF-kappaB aids in nuclear translocation and enhanced transcription and also suggest that the substrate specificity of CBP/p300 can be altered by small peptide molecules, such as HIV-encoded Tat.

HIV-1 Tat and Host AFF4 Recruit Two Transcription Elongation Factors into a Bifunctional Complex for Coordinated Activation of HIV-1 Transcription.

NOVEL MECHANISM AND HOST COFACTORS FOR REGULATION OF HIV‐1 TRANSCRIPTION

The HIV-1 Tat Protein Recruits a Ubiquitin Ligase to Reorganize the 7SK Snrnp for Transcriptional Activation

Isolation and Functional Characterization of P-TEFb-associated Factors That Control General and HIV-1 Transcriptional Elongation.

Tat Competes with HEXIM1 to Increase the Active Pool of P-TEFb for HIV-1 Transcription

PJA2 ubiquitinates the HIV-1 Tat protein with atypical chain linkages to activate viral transcription

A Cofactor, TIP30, Specifically Enhances HIV-1 Tat-activated Transcription.

Hiv-1 Tat Transcriptional Activity is Regulated by Acetylation

Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency

Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages

HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter

Enhanced NF-κB activation via HIV-1 Tat-TRAF6 cross-talk

Role of the HIV-1 positive elongation factor P-TEFb and inhibitors thereof.

Activation of Integrated Provirus Requires Histone Acetyltransferase

Enhancement of Nuclear Factor-κB Acetylation by Coactivator P300 and HIV-1 Tat Proteins

Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1.

Interaction of the Second Coding Exon of Tat with Human Ef-1 Delta Delineates A Mechanism for Hiv-1-Mediated Shut-Off of Host Mrna Translation

Human Polymerase-Associated Factor Complex (pafc) Connects the Super Elongation Complex (SEC) to RNA Polymerase II on Chromatin.

UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat

Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression

Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4.